Cargando…
Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism
BACKGROUND: Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free tes...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900935/ https://www.ncbi.nlm.nih.gov/pubmed/24450960 http://dx.doi.org/10.1186/1742-6405-11-6 |
_version_ | 1782300784450338816 |
---|---|
author | Monroe, Anne K Dobs, Adrian S Palella, Frank J Kingsley, Lawrence A Witt, Mallory D Brown, Todd T |
author_facet | Monroe, Anne K Dobs, Adrian S Palella, Frank J Kingsley, Lawrence A Witt, Mallory D Brown, Todd T |
author_sort | Monroe, Anne K |
collection | PubMed |
description | BACKGROUND: Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free testosterone (FT) and total testosterone (TT) measurements in the assessment of biochemical hypogonadism in HIV-infected and –uninfected men. METHODS: This was a cross-sectional analysis from the Multicenter AIDS Cohort Study (MACS). TT levels were measured from archived serum using liquid chromatography-tandem mass spectrometry. FT was calculated from TT and sex hormone-binding globulin (SHBG) (measured by radioimmunoassay) using the Vermeulen equation. Biochemical hypogonadism was defined as having low TT, low FT, or both. RESULTS: Of 945 men in the MACS Cardiovascular Substudy, T assays were not performed in 89 because of insufficient/no stored serum (n = 18) or use of T replacement therapy (TRT) (n = 71). 530 men had morning (AM) T measurements; 364 (68.7%) were HIV-infected. The prevalence of biochemical hypogonadism was similar in HIV-infected (34/364 = 9.3%) and HIV-uninfected (12/166 = 7.2%) men. Prevalence of hypogonadism, when men on TRT (n = 71) were included in the group of hypogonadal men, was higher in HIV-infected (104/434 = 24.0%) compared with HIV-uninfected (13/167 = 7.8%) men (p < 0.0001). Of 34 HIV-infected men with biochemical hypogonadism not on TRT, 11 (32.4%) had normal TT, but low FT. Of 12 HIV-uninfected men with biochemical hypogonadism not on TRT, none were in this category (p = 0.04) – all had low TT. CONCLUSIONS: The prevalence of biochemical hypogonadism in our sample of HIV-infected men was approximately 10%, with a substantial proportion of these men having a normal TT, but low FT. The measurement of AM FT, rather than TT, in the assessment of hypogonadism in HIV-infected men will likely increase diagnostic sensitivity and should be recommended. |
format | Online Article Text |
id | pubmed-3900935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39009352014-01-25 Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism Monroe, Anne K Dobs, Adrian S Palella, Frank J Kingsley, Lawrence A Witt, Mallory D Brown, Todd T AIDS Res Ther Research BACKGROUND: Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free testosterone (FT) and total testosterone (TT) measurements in the assessment of biochemical hypogonadism in HIV-infected and –uninfected men. METHODS: This was a cross-sectional analysis from the Multicenter AIDS Cohort Study (MACS). TT levels were measured from archived serum using liquid chromatography-tandem mass spectrometry. FT was calculated from TT and sex hormone-binding globulin (SHBG) (measured by radioimmunoassay) using the Vermeulen equation. Biochemical hypogonadism was defined as having low TT, low FT, or both. RESULTS: Of 945 men in the MACS Cardiovascular Substudy, T assays were not performed in 89 because of insufficient/no stored serum (n = 18) or use of T replacement therapy (TRT) (n = 71). 530 men had morning (AM) T measurements; 364 (68.7%) were HIV-infected. The prevalence of biochemical hypogonadism was similar in HIV-infected (34/364 = 9.3%) and HIV-uninfected (12/166 = 7.2%) men. Prevalence of hypogonadism, when men on TRT (n = 71) were included in the group of hypogonadal men, was higher in HIV-infected (104/434 = 24.0%) compared with HIV-uninfected (13/167 = 7.8%) men (p < 0.0001). Of 34 HIV-infected men with biochemical hypogonadism not on TRT, 11 (32.4%) had normal TT, but low FT. Of 12 HIV-uninfected men with biochemical hypogonadism not on TRT, none were in this category (p = 0.04) – all had low TT. CONCLUSIONS: The prevalence of biochemical hypogonadism in our sample of HIV-infected men was approximately 10%, with a substantial proportion of these men having a normal TT, but low FT. The measurement of AM FT, rather than TT, in the assessment of hypogonadism in HIV-infected men will likely increase diagnostic sensitivity and should be recommended. BioMed Central 2014-01-22 /pmc/articles/PMC3900935/ /pubmed/24450960 http://dx.doi.org/10.1186/1742-6405-11-6 Text en Copyright © 2014 Monroe et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Monroe, Anne K Dobs, Adrian S Palella, Frank J Kingsley, Lawrence A Witt, Mallory D Brown, Todd T Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title | Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title_full | Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title_fullStr | Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title_full_unstemmed | Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title_short | Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism |
title_sort | morning free and total testosterone in hiv-infected men: implications for the assessment of hypogonadism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900935/ https://www.ncbi.nlm.nih.gov/pubmed/24450960 http://dx.doi.org/10.1186/1742-6405-11-6 |
work_keys_str_mv | AT monroeannek morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism AT dobsadrians morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism AT palellafrankj morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism AT kingsleylawrencea morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism AT wittmalloryd morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism AT browntoddt morningfreeandtotaltestosteroneinhivinfectedmenimplicationsfortheassessmentofhypogonadism |